Muthusamy Shanmugam is COO at ANI PHARMACEUTICALS INC (ANIP). They have made 4 open-market trades across 1 company since 2022, most recently 2026-02-26.
CIK 0001870913
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $138K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 101,056 | $7.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2025-08-20 | 2025-08-22 | $90.36 | $18.1M | +5.5% | +5.4% | -13.7% |
| ANIP | SELL | 2025-08-14 | 2025-08-18 | $88.25 | $17.6M | +3.5% | +6.6% | -8.3% |
| ANIP | SELL · 10b5-1 | 2025-05-09 | 2025-05-13 | $76.83 | $54K | -7.1% | -0.2% | +36.4% |
| ANIP | SELL · 10b5-1 | 2024-07-18 | 2024-07-19 | $62.00 | $170K | +5.2% | -2.0% | -3.8% |
| ANIP | SELL · 10b5-1 | 2024-07-15 | 2024-07-17 | $63.60 | $3.9M | +1.0% | -4.6% | -6.9% |
| ANIP | SELL · 10b5-1 | 2024-06-21 | 2024-06-24 | $58.90 | $1.2M | -2.2% | +0.7% | -4.4% |
| ANIP | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $60.59 | $3.6M | +5.3% | +4.4% | +2.6% |
| ANIP | SELL · 10b5-1 | 2024-05-20 | 2024-05-21 | $61.81 | $1.6M | +3.0% | -3.6% | -0.6% |
| ANIP | SELL · 10b5-1 | 2024-05-15 | 2024-05-17 | $64.00 | $3.8M | +3.2% | +0.5% | -0.7% |
| ANIP | SELL · 10b5-1 | 2024-04-18 | 2024-04-22 | $65.10 | $3.5M | +1.8% | -6.4% | -5.8% |
| ANIP | SELL · 10b5-1 | 2024-04-15 | 2024-04-17 | $66.04 | $2.4M | +0.3% | -5.9% | -1.6% |
| ANIP | SELL · 10b5-1 | 2024-03-08 | 2024-03-11 | $67.17 | $672K | +5.4% | +1.8% | -1.2% |
| ANIP | SELL · 10b5-1 | 2024-03-05 | 2024-03-07 | $65.77 | $5.3M | +1.0% | +0.6% | -0.3% |
| ANIP | SELL · 10b5-1 | 2024-01-19 | 2024-01-23 | $56.06 | $2.0M | -2.5% | +2.3% | +15.4% |
| ANIP | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $55.29 | $1.9M | -2.9% | +4.6% | +17.4% |
| ANIP | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $52.51 | $3.9M | +8.9% | +5.8% | +28.8% |
| ANIP | SELL · 10b5-1 | 2023-11-17 | 2023-11-20 | $51.00 | $663K | -1.5% | +2.0% | +13.7% |
| ANIP | SELL · 10b5-1 | 2023-11-14 | 2023-11-20 | $53.00 | $3.9M | -1.5% | +2.0% | +13.7% |
| ANIP | SELL · 10b5-1 | 2023-11-14 | 2023-11-16 | $53.17 | $1.2M | -4.2% | +2.0% | +9.1% |
| ANIP | SELL · 10b5-1 | 2023-10-17 | 2023-10-19 | $57.93 | $2.3M | +7.1% | -11.0% | -3.5% |
| ANIP | SELL · 10b5-1 | 2023-10-13 | 2023-10-17 | $57.96 | $2.9M | +1.9% | -11.3% | -4.1% |
| ANIP | SELL · 10b5-1 | 2023-09-15 | 2023-09-19 | $61.83 | $5.7M | -5.5% | -6.7% | -14.6% |
| ANIP | SELL | 2023-08-28 | 2023-08-30 | $63.22 | $3.2M | -4.1% | -10.1% | -22.1% |
| ANIP | SELL · 10b5-1 | 2023-08-14 | 2023-08-16 | $61.28 | $4.8M | +5.8% | +5.2% | -10.3% |
| ANIP | SELL · 10b5-1 | 2023-07-19 | 2023-07-21 | $51.91 | $1.5M | -2.4% | +16.8% | +9.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.